But early disclosures have been known to kill IP, Johnson pointed out...Every patent that was filed on every intranasal delivery of everything we eliminated, because we didn't have enough clinical data to support it," he said...In August, Marina licensed the patent rights to its long-acting analogue of oxytocin, known as carbetocin, which is being developed as an autism therapy, and related technology to Cypress Biosciences Inc

Defendant*Plaintiff Details/ Decisions (Date)# AbbottCentocor Ortho Biotech Inc.A federal jury in Texas awarded Centocor $1.67B against Abbott in a patent infringement suit involving the companies' antitumor necrosis factors used to treat arthritis...patent covering methods of treating human disease by regulating NF-kB cell-signaling activity...in Lilly's appeal, the court found that the four claims are not valid due to inadequate written description, but affirmed the court's ruling that the patent

It's amazing to all of us that a single case of bad rash that the experts have said is not Stevens-Johnson syndrome" would yield the decision, he added...Cephalon conducted the study to gain an "enormously valuable" six-month patent extension on the product, Grupp told BioWorld Today, but never had any designs on expanding its label for children...A further SEC filing on Form 10-Q for the latest quarter will be filed no later than Monday to reflect the not-approvable letter's impact on the financial

BioVeris paid an initial $150,000 license issue fee and may make additional payments for license maintenance and patent costs, as well as for milestone achievements and royalties

We realized it would position us to create value that we wouldn't be able to create otherwise," Crane said this month at the Biotechnology Industry Organization's 2005 annual international convention in Philadelphia...Although he knew going public would change the nature of his job - he would need to devote a large amount of time to disclosures and filings and other requirements - he was concerned about missed opportunities and the cost of not being able to access capital...By going public, the reward

It believes the notices relate to the company's disclosures concerning its communications with the FDA about a trauma study protocol submitted to the agency in March 2003, as well as its biologics license application for Hemopure (hemoglobin glutamer - 250 [bovine...Medicure Inc., of Winnipeg, Manitoba, received C$14.6 million (US$11.2 million) after investors exercised 99 percent of the company's common share purchase warrants and agents' compensation units

Copernicus Therapeutics Inc., of Cleveland, was issued US Patent No...patent for a synthetic DNA that permits gene therapy without injecting viruses that may pose significant risks to humans...patent covering its EvoGene technology platform, designed to generate and identify proteins with properties tuned for their required task

Frates told BioWorld Today that Alkermes, even as it serves its partners, has been taking aim at drug development, using off-patent (which Frates prefers to call “multisourced”) compounds and others already approved or in development by partner firms. “That’s exactly what Alza did,” Frates noted, citing New Brunswick, N.J.-based Johnson & Johnson’s buyout of Alza Corp., of Mountain View, Calif., in a deal with a net equity estimated at $10.5 billion. “And a major reason they bought...Human growth

The procedure is related to Alexion's work in xenotransplantation. * Alfacell Corp., of Bloomfield, N.J., received patent No...Onconase is an RNase protein. * Ansan Inc., of South San Francisco, received patent No...5,554,746, "Synthesis of lactam nucleic acids." * Oxford Molecular Group plc., of London, received patent No

He said Immunex, in filing its patent, copied each of the seven errors in exactly the same position...Cistron's patent relates only to inactive forms of IL-1b, Immunex said...When Immunex filed its patent claiming and describing the DNA sequence for active IL-1b, it included the sequence of the longer, precursor IL-1b that had been disclosed in Germany in 1984 for description purposes only, and not as a claimed invention, Immunex said

patent No...patent covering for a universal-tumor marker detection system. * Biocontrol Technology Inc., of Pittsburgh, said it was issued a U.S...patent on a specialized method for whole-body extracorpeal hyperthermia used in treatment of HIV. * Ribozyme Pharmaceuticals Inc., of Boulder, Colo., said two more patents covering its ribozyme technology were issued